BiotechTube
Home/Optimvia/James E. Rothman, PhD
JE

James E. Rothman, PhD

Director

Optimvia

Therapeutic Areas

AnticoagulationThrombosis

Optimvia Pipeline

DrugIndicationPhase
Biosynthetic HeparinAnticoagulation/AntithrombosisPre-clinical

Leadership Team at Optimvia

KM
Keith M. Kleeman
CEO and Chair of the Board
SG
Steve Geis, PhD, MD
Director
MK
Mick Kowitz
Director
View full Optimvia profile